Clinical Trial Update: Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 trial comparing liposomal bupivacaine to standard bupivacaine in the adductor canal for total knee arthroplasty; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis of the Knee
• Pain

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Pain | Phase 4 | Status: TERMINATED | Results posted: 2019-06-25